RSLBF Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (5 Jan 2024 @ 09:54):

Stats
Today's Volume	3 409.00
Average Volume	4.00
Market Cap	285.58M
EPS	$0.410 ( 2023-02-27 )
Next earnings date	( $0 ) 2024-05-17
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	49.00
ATR14	$0.0840 (0.90%)

Volume Correlation

Long: -0.15 (neutral)

Short: 0.00 (neutral)

Signal:(93.442) Neutral

RaySearch Laboratories AB Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

RaySearch Laboratories AB Correlation - Currency/Commodity

0.61
( weak )

0.16
( neutral )

-0.67
( moderate negative )

0.20
( neutral )

-0.72
( moderate negative )

0.61
( weak )

RaySearch Laboratories AB Financials

Annual	2023
Revenue:	$100.89M
Gross Profit:	$62.22M (61.67 %)
EPS:	$0.230

FY	2023
Revenue:	$100.89M
Gross Profit:	$62.22M (61.67 %)
EPS:	$0.230

FY	2022
Revenue:	$80.57M
Gross Profit:	$43.18M (53.59 %)
EPS:	$0.0662

Financial Reports:

No articles found.

RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities. In addition, it offers RayCommand, a treatment control system that is compatible with various hardware models and supports advanced functionalities of treatment machines and software systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.